Pulse Oximeters in Virginia

Kerma Medical Products, Inc. is a healthcare medical device manufacturer and direct distributor established in 1991, based in Suffolk, Virginia. The company operates dual business divisions: a manufacturing division providing contract manufacturing, assembly, and packaging services to medical device companies, and a direct sales division serving over 4,000 healthcare locations including hospitals, acute care facilities, and durable medical equipment providers. Kerma manufactures and distributes wound care and pressure management products, patient monitoring devices, neonatal equipment, and body fluid management systems. The company is certified as a Virginia and New York state diversity supplier and holds contracts with major healthcare GPOs including HealthTrust, Premier, Vizient, and Novaplus, ensuring reliable access to quality medical products at competitive pricing with streamlined order tracking and timely delivery.

OxiWear Inc manufactures FDA-cleared wearable pulse oximetry devices designed for continuous, real-time monitoring of blood oxygen saturation and pulse rate. The company's flagship product is an ear-worn oximeter that delivers medical-grade accuracy during rest and physical activity, with particular advancement in consistent performance across diverse skin tones. The device provides second-by-second measurements via patented technology and integrates wireless connectivity for data sharing with clinicians through mobile apps, text alerts, and vibration notifications when oxygen levels fall below user-defined thresholds. OxiWear targets patients with chronic respiratory and cardiac conditions including pulmonary hypertension, COPD, cystic fibrosis, and pulmonary fibrosis, as well as athletes and individuals requiring supplemental oxygen therapy. The company positions its solution as an alternative to traditional finger-based pulse oximeters, addressing limitations in comfort, mobility, and accuracy—particularly for patients with darker skin pigmentation or conditions like Raynaud's syndrome that compromise finger-based readings. Clinical endorsements from leading institutions (Johns Hopkins Pulmonary Hypertension Program) and patient testimonials emphasize enhanced independence and real-time safety monitoring. OxiWear has received FDA clearance as a medical device and is supported by major health organizations including the American Heart Association, Pulmonary Hypertension Association, COPD Foundation, and Cystic Fibrosis Foundation.